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ABSTRACT
Generation of mesencephalic dopamine (mesDA) neurons
from human embryonic stem cells (hESCs) requires sev-
eral stages of signaling from various extrinsic and intrinsic
factors. To date, most methods incorporate exogenous
treatment of Sonic hedgehog (SHH) to derive mesDA neu-
rons. However, we and others have shown that this
approach is inefﬁcient for generating FOXA21 cells, the
precursors of mesDA neurons. As mesDA neurons are
derived from the ventral ﬂoor plate (FP) regions of the
embryonic neural tube, we sought to develop a system to
derive FP cells from hESC. We show that forced expres-
sion of the transcription factor GLI1 in hESC at the ear-
liest stage of neural induction, resulted in their
commitment to FP lineage. The GLI11 cells coexpressed
FP markers, FOXA2 and Corin, and displayed exocrine
SHH activity by ventrally patterning the surrounding neu-
ral progenitors. This system results in 63% FOXA21 cells
at the neural progenitor stage of hESC differentiation.
The GLI1-transduced cells were also able to differentiate
to neurons expressing tyrosine hydroxylase. This study
demonstrates that GLI1 is a determinant of FP speciﬁca-
tion in hESC and describes a highly robust and efﬁcient in
vitro model system that mimics the ventral neural tube or-
ganizer. STEM CELLS 2010;28:1805–1815
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION
In the last decade, since the derivation of human embryonic
stem cell (hESC) lines, there has been much effort in generating
mesencephalic dopamine (mesDA) neurons from hESC for
developing cell replacement therapies to treat Parkinson’s dis-
ease [1–3]. The ideal approach for deriving mesDA neurons
from hESC is to mimic embryonic ventral midbrain develop-
ment in culture. The ventralization aspect of the differentiation
protocol is especially important as dopaminergic neurons are
found within multiple regions in the brain and speciﬁc ventral
markers need to be used to identify the ‘‘true’’ mesDA neuron.
During mouse embryogenesis, the ﬁrst postmitotic mesDA neu-
rons can be identiﬁed by Nurr1 expression at E10.5 [4] and
then later, at E11.5, are immunoreactive for tyrosine hydroxy-
lase (TH) [5]. These TH neurons arise from the ventral regions
of the mesencephalon [6, 7], as identiﬁed by the expression of
transcription factors known to be critical for the development of
mesDA progenitor cells. FoxA2 is one such gene expressed in
the mesDA progenitor cells and its expression is maintained in
adult mesDA neurons [8, 9]. Heterozygous FoxA2 mutants
show a progressive loss of mesDA neurons in adult mice indi-
cating its requirement for mesDA survival [8].
In addition to mesDA progenitors, FOXA2 is expressed
within the neighboring ﬂoor plate (FP) regions of the ventral
neural tube [10]. The development of the FP is dependent on
Sonic hedgehog (SHH) signaling. SHH is initially produced
in the notochord during gastrulation, which in turn induces
the neighboring neural tube FP to also secrete SHH, thereby
creating a ventralizing signaling organizer [11]. In mice, loss
of SHH reveal that it is a key morphogen required for the de-
velopment of the FP [12] and its concentration gradient is
instrumental in specifying the dorsoventral identity of cells
throughout the neural tube [13]. Within the FP regions, where
SHH concentrations are endogenously the highest, SHH
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target of Gli1 as previous studies in mouse embryos have
shown that forced Gli1 expression in dorsal neural progenitors
resulted in ectopic FoxA2 expression [15].
Obtaining a ventral identity of FP cells is a key step in
the speciﬁcation of midbrain neural cells toward a mesDA
neural fate. Over years, there have been several protocols
developed for inducing midbrain dopaminergic neurons from
mouse embryonic stem (ES) cells and hESC [16–19]. Some
of these methods involve supplementation of exogenous SHH
or rely on endogenous SHH production and as well as other
ventralizing factors within the cultures, to induce ventraliza-
tion of neural progenitors [16–23]. The effectiveness of exog-
enous SHH treatment in ventralizing neural progenitors
depends on the potency. Our data shows that exogenous treat-
ment of C24II human recombinant Shh is ineffective in upre-
gulating FOXA2 expression despite using a range of SHH
concentrations and timing of treatment. Likewise, previous
studies reported relatively low levels of FoxA2þ cells gener-
ated from SHH-treated neural progenitors derived from pri-
mate ES cells [21]. A more recent study from Fasano et al.
[24] showed mouse recombinant Shh (C25II) to be signiﬁ-
cantly more effective in ventralizing human neural progenitors
and generated FP cells. In our study, we undertook an intrin-
sic approach to upregulate FOXA2 expression and induce FP
cells from hESC. Our studies show that inducing GLI1
expression in hESC, at the earliest stage of neurogenesis,
results in their commitment to FOXA2þ FP progenitor cells
at high efﬁciency. The hESC-derived FP cells were capable
of patterning neighboring cells into a range of ventral cell
types through the secretion of SHH. Furthermore, a proportion
of these FP progenitor cells can further differentiate into ven-
tral dopamine neurons. These studies were performed in a
feeder-free culture system and demonstrate that GLI1 is a
potent inducer of FP cells at the earliest onset of hESC neural
differentiation. Overall, we describe the creation of an in vitro
model system that mimics the ventral neural tube organizer.
MATERIALS AND METHODS
hESC Culture
HES-3 (Madison, WI, www.wicell.org), ENVY-HES-3 (Genome,
Singapore, www.biotimeinc.com/esi/), and HUES-10 [25] cell
lines were cultured as previously described [26, 27]. Brieﬂy,
hESCs were culture on mitomycin-C treated mouse embryonic
ﬁbroblasts (MEFs) in hESC medium consisting of high-glucose
Dulbecco’s Modiﬁed Eagle Medium (DMEM) without sodium
pyruvate, supplemented with insulin/transferrin/selenium 1%, b-
mercaptoethanol 0.1 mM, nonessential amino acids (NEAA) 1%,
glutamine 2 mM, penicillin 25 U/ml, streptomycin 25 lg/ml (all
from Mulgrave, Australia, www.invitrogen.com) and fetal calf se-
rum (FCS) 20% (Scoresby, Australia, www.hyclone.com/) at
37 C–5% CO2. Colonies were mechanically dissected every 7
days and transferred to freshly prepared MEFs. Media was
changed every second day.
PA6 Neural Induction
hESCs were mechanically dissected into pieces approximately 0.5
mm in diameter and transferred to an organ culture plate of PA6
cells (Koyadai, Japan, www.brc.riken.go.jp/lab/cell/) in coculture
medium containing Glasgow minimum essential medium, supple-
mented with 8% knockout serum replacement, 1% NEAA, 2 mM
L-glutamine, 1 mM sodium pyruvate, b-mercaptoethanol 0.1 mM,
2 mM, penicillin 25 U/ml, streptomycin 25 lg/ml. Cells were dif-
ferentiated on PA6 cells for 12 days with Noggin (500 ng/ml, Min-
neapolis, MN, www.rndsystems.com) added to the media for the
ﬁrst 4 days. Following PA6 coculture neural rosettes were dis-
sected into 0.5-mm fragments and further cultured in suspension in
low-attachment 96-well plates (Mount Martha, Australia,
www.corning.com) in N2B27 medium containing 1:1 mix of neuo-
basal medium with DMEM: nutrient mixture F-12 medium, sup-
plemented with insulin/transferrin/selenium 1%, N2 1%, B27 1%,
glucose 0.3%, penicillin 25 U/ml, and streptomycin 25 lg/ml (all
from Invitrogen), as neurospheres with basic Fibroblast Growth
Factor (bFGF) and Epidermal Growth Factor (EGF) (20 ng/ml
each, R&D). After 7–10 days neurospheres were plated onto lami-
nin-coated dishes in N2B27 medium without EGF and bFGF, sup-
plemented with 1 mM dibutyryl-cAMP (Castle Hill, Australia,
www.sigmaaldrich.com). For certain experiments SHH-N (200–
1,000 ng/ml, R&D 1845-SH, C24II) was added to the coculture
medium during neural induction.
Neural Induction in Deﬁned Medium
hESCs were mechanically dissected into pieces approximately
0.5 mm in diameter and transferred to laminin-coated organ culture
plate in N2B27 medium for 12 days, with Noggin (500 ng/ml,
R&D) added to the media only for the ﬁrst 6 days followed by the
addition of bFGF (20 ng/ml each, R&D) for the remaining 6 days.
Following neural induction, the monolayer of neural progenitors
were dissected into approximately 1 mm fragments and further
cultured in suspension in low-attachment 96-well plates (Corning) in
N2B27 medium supplemented with bFGF and EGF (20 ng/ml each,
R&D). After 7–10 days neurospheres were plated onto laminin-
coated dishes in N2B27 medium without EGF and bFGF, supple-
mented with 1 mM dibutyryl-cAMP (Sigma) for 7–10 days.
Fluorescent Activated Cell Sorting Analysis
Neural stem cells (NSCs) were dissociated into single cells with
TrypLE Express (Invitrogen) and ﬁxed with 4% paraformalde-
hyde (PFA) for 10 minutes followed by premeabelization in 90%
methanol. NSCs were immunolabeled with goat anti-FoxA2
(Santa Cruz, CA, www.scbt.com, dilution 1:300) or rabbit anti-
TH (1:1000, Rogers, AR, www.pelfreez-bio.com) or mouse anti-
TUJ1 (1:500, Sydney, Australia, www.promega.com) in blocking
solution (Phosphate buffered saline-0.25% Triton X; PBT þ10%
FCS þ10% FCS) for 60 minutes, and then were resuspended in
appropriate Cy5 or Cy2 secondary antibodies (West Grove, PA,
www.jacksonimmuno.com) for 30 minutes, followed by a wash
in blocking solution before being immediately sorted using a
FACSCalibur cell sorter.
Immunostaining
Cell monolayers and neurospheres were ﬁxed in 4% PFA for 20
minutes at 4 C and then washed brieﬂy in Phosphate buffered sa-
line (PBS). Neurospheres were embedded in Tissue-Tek OCT
compound (Brendale, Australia, www.labtek.com.au), cut at 8 lm
on a cryostat, and sections were placed on superfrost slides. Sec-
tions or culture dishes were blocked for 1 hour at room tempera-
ture (RT) in blocking solution. The following primary antibodies
were used: goat anti-FoxA2 (1:300, Santa Cruz), mouse anti-
Nkx2.1 (1:300, Cambridge, MA, www.abcam.com) goat anti-
Sox2 (1:500, R&D), rabbit anti-Otx2 (1:1,000, North Ryde,
NSW, Australia, www.millipore.com) rabbit anti-Corin (1:100;
[28]), rabbit anti-TH (1:1,000, Pel Freez), mouse anti-Tuj1
(1:500, Promega), rabbit anti-Ki67 (prediluted, Thermoscientiﬁc),
guinea pig anti-Lmx1b (1:5,000, gift Thomas Perlmann), mouse
anti-Pax6 (1:40), mouse anti-Pax7 (1:40), mouse anti-En1 (1:40),
and mouse anti-Nkx6.1 (1:10; all from Iowa City, Iowa dshb.bio-
logy.uiowa.edu). Antibodies were diluted in blocking solution
incubated on sections overnight at 4 C. Following three 10-minute
washes in PBT, the corresponding secondary antibodies were applied
for 1 hour at RT: anti-goat Cy3, anti-mouse Cy3, ant-guinea pig Cy3,
anti-rabbit Cy3, anti-rabbit Cy5, and anti-mouse Cy5 (1:400, Jackson
Immunoresearch). Sections and cultures were counterstained for 10
minutes with Hoechst 33342 (5 lg/ml). Slides were mounted in
PVA-DABCO for viewing under an immunoﬂuorescent microscope
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were captured using the Cell-M software. Confocal microscopy was
performed using a North Ryde, Australia, www.zeiss.com.au or pascal.
Reverse Transcription Polymerase Chain Reaction
Total RNA was isolated from cell pellets using the RNeasy Mini
Spin Kit (Doncaster, Australia, www.qiagen.com) as per the manu-
facturer’s instructions. RNA was quantiﬁed using a spectrophotome-
ter, and 300 ng were transcribed using Superscript III (Invitrogen)
as per the manufacturer’s instructions. Negative controls were
treated in the same fashion, but no Superscript III was added to the
reaction mix. Standard polymerase chain reaction (PCR) was car-
ried out using Taq DNA polymerase (Alexandria, Australia,
www.bioline.com), gene-speciﬁc primers for SHH, dispatched hom-
olog 1 (DISP1), and b-actin were designed (Supporting Information
data; Hindmarsh, Australia, www.geneworks.com.au) and annealing
temperatures of 55 C with ampliﬁcation for 35 cycles. PCR prod-
ucts were resolved by agarose gel electrophoresis.
Lentivirus Production and Neural Infection
293T cells were transfected by CaCl2 with the following plasmid
combinations. pBR8.91 and pMDG.2 were mixed with 2K7-Ef1a-
GFP-neo or 2K7-Ef1a-GLI1-IRES-EGFP-neo or RRL-Ef1a-
GLI1-IRESGFP to generate lentiviral particles (see Supporting
Information). Viral supernatant was harvested over 2 days and
concentrated by ultracentrifugation. The concentrated lentiviral
supernatant was titered on 293T cells to determine functional
transducing units. NSCs were infected with 10 times the number
of infectious particles per cells. Abbreviations: El1a, Elongation
Factor 1 alpha; IRES, internal ribosome entry site; EGFP,
enhanced green ﬂuorescent protein.
Statistical Method
The method used to quantify positive gene expression, as
detected by immunostaining, was by using Image software pro-
gram (www.scioncorp.com). Brieﬂy, sections were photographed
using an Olympus IX81 ﬂuorescent microscope using the Cell-M
software and/or a Zeiss LSM 510 meta or pascal confocal micro-
scope using the LSM Zen software. Fluorescent objects were
identiﬁed by the threshold function and evaluated by quantiﬁca-
tion of total number of pixels per section using Scion Image. The
level of positive staining for gene of interest was measured by
the same threshold and analyzed as a percentage of total pixels
from the respective Hoechst image. Fluorescent Activated Cell
Sorting (FACS) quantiﬁcation of FOXA2, TH and b-III tubulin
(TUJ1) were performed by analysis of at least 10,000 events per
replicate. All experiments were repeated at least three times.
One-way ANOVAs were performed for statistical analyses.
RESULTS
Neural Differentiation of hESCs on PA6 Yields Few
Ventral Dopamine Neurons
Differentiation of hESCs on the PA6 stromal cell line has
been used extensively to direct their differentiation toward a
NSC lineage. We have optimized a neural differentiation pro-
tocol utilizing PA6 cells supplemented with Noggin for the
initial neural induction (stage A), neural expansion as neuro-
spheres (stage B), and a ﬁnal neuronal differentiation (stage
C) on laminin. Stage A is characterized by the presence of
neural rosettes that are immunopositive for pan-markers of
early NSCs, SOX2 and PAX6 (Fig. 1B, 1C), as well as the
forebrain-midbrain marker, OTX2 (Fig. 1D). These results are
consistent with previously described hESC neural differentia-
tion assays that yield a default rostral identity [29]. NSCs
were then expanded as ﬂoating neurospheres (stage B) and
further differentiated on laminin in the absence of exogenous
growth factors to induce postmitotic neural differentiation
(stage C), as indicated by the expression of the early postmi-
totic neuronal marker, TUJ1 (Fig. 1D). Further assessment of
dopamine neuronal identity was conducted by identifying ven-
tral dopamine neurons with the colocalization of FOXA2 and
TH at stage C (Fig. 1E and Supporting Information Fig.
S1D). It was rarely found that FOXA2 and TH colocalized
(0.40% 6 0.29% SEM THþ/FOXA2þ, Supporting Informa-
tion Fig. S1D). This suggests using the PA6/Noggin system
for hESC neural differentiation results in a low frequency of
midbrain dopaminergic neurons.
Recombinant SHH-N Suppresses PAX7
Dorsal Progenitors but Does Not Increase
FOXA2 Ventral Progenitor Cells
The low frequency of dopaminergic neurons in the standard
PA6/Noggin neural differentiation protocol may be due to a
lack of the appropriate regionalization signals at early stages
of neural induction/differentiation to bias the speciﬁcation of
neural progenitors to a ventral midbrain fate. To determine
the dorsal-ventral identity of neural progenitors derived by
PA6/Noggin neural induction, PAX7 expression was analyzed
in neural rosettes (stage A). It was found that 53.66% 6
3.44% SEM of the colony expressed PAX7, suggesting a bias
toward dorsal phenotype (Fig. 2A).
During embryogenesis, neuroepithelial cells in the ventral
neural tube are speciﬁed by gradient levels of SHH released
by the underlying notochord and FP. Thus, exogenous SHH
has been used in several neural differentiation protocols to
specify cells into a ventral lineage [23, 30]. Addition of
recombinant SHH-N at day1 of differentiation (stage A), at
various doses, was assessed for its ability to generate FOXA2
expressing cells. Without SHH treatment, only 2.6% 6 0.49%
SEM FOXA2 and 0.09% 6 0.06% SEM NKX6.1 were
observed (Fig. 2A, 2E). When 200 ng/ml recombinant SHH-N
was added from day 1, there was a signiﬁcant decrease in
PAX7 expression (p < .001; Fig. 2A, 2C, 2D) and a corre-
sponding signiﬁcant increase in NKX6.1 (p < .0045; Fig. 2A,
2E, 2F). However, no signiﬁcant difference in FOXA2 was
detected (Fig. 2A). A dose-response of SHH-N was conducted
with up to 800 ng/ml of SHH-N and the levels of FOXA2
expression were again assessed. No signiﬁcant increase in
FOXA2 expression was detected, with even the highest
amount of SHH-N added (Fig. 2B). However, a signiﬁcant
reduction in the number of FOXA2þ cells was observed
when the cultures were treated with the SHH antagonist,
SANT-1 (p < .0092; Fig. 2B). Thus, although exogenous
treatment using recombinant SHH does not seem to be effec-
tive in increasing the proportion of FOXA2þ cells, SHH is
required for inducing FOXA2 expression.
Neural Differentiation of hESCs in Deﬁned
Medium Generates Early Rosettes Before
Dorsoventral Commitment
The aforementioned data showed that when using PA6 cocul-
ture for hESC neural induction, the onset of PAX7 expres-
sion was detected during the neural induction stage, stage A.
This suggests that PA6 may differentiate hESCs to speciﬁed
neural precursors rapidly and thus, for temporal reasons, it is
difﬁcult for cells to be responsive to factors supplemented
within the medium. We therefore sought to develop a differ-
entiation system in the absence of PA6 to have a temporal
window of uncommitted early neural precursors. hESCs were
plated on laminin in deﬁned N2B27 medium supplemented
with Noggin for 12 days (Fig. 3A; stage A0) and then
assessed for dorsalventral neural patterning markers. At stage
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PAX6þ and SOX2þ rosette-forming cells. In addition, there
is no detected expression of regional markers PAX7,
NKX6.1, and FOXA2 (Fig. 3D). These features taken to-
gether are characteristic of early neural precursors [31].
Using this neural induction protocol, SHH at 200 ng/ml or
1,000 ng/ml was supplemented in the media and levels of
FOXA2 expression was analyzed (Supporting Information
Fig. S2). It was found that, similar to the PA6 coculture neu-
ral induction system, only on rare occasions are FOXA2 cells
detected at stage A0 even in the presence of high levels
(1,000 ng/ml) of recombinant SHH. This data suggest that
the default pathway of neural induction and differentiation
results in a low population of FOXA2 cells and additional
extrinsic and/or intrinsic signals are required to specify
hESC-derived neural precursors to a ventral fate.
Misexpression of GLI1 Induces FP
Speciﬁcation of NSCs
Given the lack of effectiveness for recombinant SHH to
induce FOXA2 expression, an alternative approach of using
intrinsic signals was undertaken to specify hESC-derived neu-
ral precursors to a ventral fate. The candidate intrinsic signal
chosen was the transcription factor GLI1. Gli1 is initially
coexpressed with FoxA2 cells in the embryonic FP region of
the neural tube and is a direct downstream target of Shh [7].
Additionally, Gli1 does not contain an N-terminal repressor
domain, which in the case of Gli2 and Gli3 can be activated
after cleavage [32].
Using lentiviral technology, hESC-derived neural pre-
cursors were infected at stage A0 with a GLI1-IRES-EGFP
virus driven by a constitutively active promoter. At 12 days
after infection with GLI-IRES-EGFP, 63.27% 6 4.85%
SEM cells were FOXA2þ (Figs. 4A–4C, 5). Coexpression
of the ventral neural tube marker, Corin, and Green Fluores-
cent Protein (GFP) were also observed (Fig. 4E–4K). In
addition, 11.76% of cells within the cultures expressed the
SHH-responsive and basal plate marker NKX6.1 (data not
shown). Neural progenitors infected with control virus
(EGFP), resulted in no detectable FOXA2 expression (Fig.
4D). Thus, similar to the embryonic neural tube, GLI1
expression induces FOXA2 expression and ventralizes neu-
ral progenitors.
Figure 1. Few hESCs differentiate into ventral dopamine neurons. (A): hESCs are differentiated on PA6 cells for 12 days and form neural
rosettes (stage A). Neural rosettes are dissected and cultured as ﬂoating spheres (stage B). Terminal differentiation of neurospheres results in neu-
ronal differentiation (stage C). (B): Colocalization of PAX6 and SOX2 is observed during differentiation of hESCs to stage A. (C): Stage A neu-
ral rosettes express the forebrain marker OTX2. (D): Stage C neural cells express TUJ1 with a subset of cells colocalize for TH. (E): Few cells
at stage C are positive for the ventral neural marker FOXA2þ and those which are not colocalize with the dopamine marker TH (arrow indicates
THþ/FOXA2  cells). Scale bar ¼ 100 lm. Abbreviations: hES, human embryonic stem; TH, tyrosine hydroxylase; TUJ1, b-III tubulin.
1808 GLI1 Induces Floor Plate in Human ESCsInterestingly, in the GLI1-transduced cultures 25.09% 6
1.79% SEM FOXA2þ cells did not coexpress GFP (Fig. 5).
The FOXA2þ/GFP- population may arise from transduced
cells that subsequently silenced GFP expression. Alterna-
tively, or perhaps in addition to, the FOXA2þ/GFP  cells
may arise from local signals secreted by the GFPþ cells,
namely, SHH, somewhat mimicking the embryonic neural
tube FP. Indeed, this latter hypothesis is supported by the ob-
servation that the GLI1-tranduced cultures show the presence
of NKX6.1þ/GFP  cells, which was undetected in nonin-
fected controls (Fig. 6C).
To determine the mechanism by which FOXA2þ/GFP 
cells were derived from, coculture experiments were per-
formed whereby a constitutively expressing GFP cell line,
ENVY was infected with GLI1-IRES-GFP. Following
infection, ENVY cells were harvested and then cocultured
with a non-GFP hESC line, HES-3, for 12 days after
which FOXA2þ/GFP  cells were identiﬁed (Supporting
Figure 2. Recombinant SHH can suppress dorsal speciﬁcation, but does not increase ﬂoor plate speciﬁcation. (A): Bar graph showing percen-
tages (6SEM) of stage A cells expressing the dorsoventral marks PAX7, NKX6.1 and FOXA2, and the pluripotent marker OCT4. Comparison of
stage A cells treated with and without SHH-N (200 ng/ml). A signiﬁcant decrease in PAX7 (p < .001) and a signiﬁcant increase in NKX6.1 (p
< .0045) is observed. (B): Bar graph shows various concentrations of SHH-N (200–800 ng/ml) do not signiﬁcantly increase FOXA2 cells at stage
A. However, a signiﬁcant reduction in FOXA2 cells is seen with the inhibitor SANT-1 (p < .0092). (C, D): Immunoﬂuorescence of PAX7 in col-
onies treated with and without SHH-N. (E, F): Immunoﬂuorescence of NKX6.1 in colonies treated with and without SHH-N. Scale bar ¼ 100
lm. Abbreviations: SHH, Sonic hedgehog; SHH-N, recombinant human N-terminal Sonic hedgehog.
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GLI1-expressing cells are inﬂuencing the neighboring cells
to also be ventralized. Overall, these data demonstrates
that GLI1 is a potent factor for ventralizing neural progeni-
tors, by mediating its function both intrinsically and
extrinsically.
GLI1-Transduced Cells Secrete SHH
GLI1-transduced neural progenitors were further differentiated
to neurospheres and the expression of dorsalventral regional
markers were analyzed at this stage of differentiation, stage
B0. GFP expression persisted at the neurosphere stage, and
Figure 3. Differentiation of hESCs in deﬁned media with Noggin results in uncommitted neuroepithelial cells, which can further differentiate
into neurons. (A): hESCs are differentiated on laminin in deﬁned medium for 12 days and form early neural rosettes (stage A0). Neural rosettes
are dissected and cultured as ﬂoating spheres (stage B0). Terminal differentiation of neurospheres results in neuronal differentiation (stage C0). (B,
C): Stage A0 neural cells express PAX6 and SOX2. (D): Bar graph shows at stage A0 early neural rosettes express no dorsoventral markers and
do not express the pluripotent stem cell marker OCT4, as assessed by immunoﬂuorescence. In contrast, 96.75% (61.031 SEM) and 87.96%
(62.063 SEM) of cells express the neuroepithelial stem cell marker SOX2 and PAX6, respectively. Scale bar ¼ 100 lm. Abbreviations: EGF,
Epidermal Growth Factor; FGF2, Fibroblast Growth Factor 2; hES, human embryonic stem.
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to stage A0, there were FOXA2þ/GFP  cells present (Fig.
6A), as well as expression of Corin (Fig. 6D), NKX6.1 (Fig.
6C), and NKX2.1 (Fig. 6B).
The mechanisms by which GLI1 is inducing expression of
ventral markers in neighboring cells may be through its secre-
tion of SHH, as previous studies have suggested in other spe-
cies [33, 34]. Reverse transcription polymerase chain reaction
Figure 4. Misexpression of GLI1 in stage A0 cells results in upregulation of FOXA2 and the ﬂoor plate marker Corin. (A–C): GLI1-IRES GFP lentivi-
rus induces FOXA2 expression in infected cells (arrow) and GFP-/FOXA2þ cells can also be found (arrowhead). (D): Control GFP lentivirus does not
induce FOXA2 expression. (E–K): Double-positive FOXA2 and Corin cells are observed in the GLI1-IRES GFP-infected cells. Some of the FOXA2þ/
Corinþ cells showed low or no expression of GFP ([F–H], arrowhead), however, several GLI1-IRES GFP-infected cells showed to be double-positive
FOXA2/Corin ([I–K], arrow). Scale bar ¼ 50 lm( A–E), 20 lm( F–K). Abbreviations: EF1a, Elongation Factor 1 a; GFP, Green Fluorescent Protein.
Figure 5. FACS analysis of GLI1-transduced colonies reveal FOXA2-positive cells, which do not coexpress GFP. (A): FACS analysis of stage A0
cells infected with GLI1-IRES-GFP lentivirus showed 38.2% (64.40 SEM) FOXA2þ/GFPþ and 25.09% (61.79 SEM) FOXA2þ/GFP  cells. (B):
Isotype control FACS. Abbreviations: Ef1a, Elongation Factor 1 a; EGFP, Enhanced Green Fluorescent Protein; IRES, Internal ribosome entry site.
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transduced progenitors and control GFP-transduced progeni-
tors. SHH transcripts were detected in neurospheres derived
from GLI1-transduced progenitors only (Supporting Informa-
tion Fig. S4), further supporting the FP-like activity of GLI1-
expressing neural progenitors.
High Levels of FOXA2 Expression is Maintained on
Terminal Differentiation of Neurospheres Derived
from GLI1-Transduced Cells
Expression of Ki67 was analyzed in neurospheres derived
from GLI1-transduced cells to determine whether the Gli1þ/
GFPþ cells are able to differentiate into postmitotic progeni-
tors (Supporting Information Fig. S5). Both populations of
GFPþ/Ki67þ and GFPþ/Ki67  cells were observed suggest-
ing that GFPþ cells are capable of terminal differentiation.
Neurospheres derived from GLI1-expressing cells were
then further differentiated onto laminin in the absence of mi-
togens to promote their differentiation to postmitotic neurons
and glia (stage C0). At stage C0, it was found that the levels
of GFPþ expression drops to 12.94% 6 3.551% SEM, as
compared with 44.2% 64.044% SEM at stage A0 (Figs. 5,
7P). This supports the notion of silencing of the transgene
over time and on differentiation. Despite this signiﬁcant (p <
.0022) decrease in GFP expression, the levels of FOXA2
maintained to be signiﬁcantly high (25.37% 6 3.106% SEM;
p < .0067; Fig. 7P). Several FOXA2 cells also coexpressed
b-tubulin (Fig. 7A–7G), and 1.63% 60.24% SEM were
FOXA2þ/THþ (Fig. 7H–7N and Supporting Information Fig.
S1). The low levels of FOXA2þ/THþ expression found in
the differentiated GLI1-transduced cultures suggests a lack of
midbrain speciﬁcation and perhaps instead these cultures are
fated toward a more anterior identity. In support of this, very
few LMX1Bþ and Engrailed 1þ, both mesDA neural progen-
itor markers, were detected in the GLI1-transduced cultures at
stages B0 and C0 (Supporting Information Fig. S6). In all,
these data demonstrates that GLI1 is a potent inducer of
FOXA2 expression in neural precursors and consequently
may therefore bias their fate toward ventral neurons of the
neural tube.
DISCUSSION
Differentiation of hESC into speciﬁc neuronal lineages
requires having precise temporal and spatial patterning sig-
nals, similar to embryonic neural development, to commit
their differentiation toward certain cell fates and prevent
their differentiation down alternate lineages. SHH is a key
morphogen in establishing a dorsoventral neural patterning
Figure 6. GLI1-transduced stage
A0 neural cells form neurospheres
(stage B0), which maintain ﬂoor
plate and ventral neural stem cell
markers. (A): GLI1-infected cells
maintain FOXA2 expression in
neurospheres and FOXA2þ/GFP 
cells can be seen in close proxim-
ity to FOXA2þ/GFPþ cells
(arrow). (B): The GFPþ/FOXA2þ
did not colocalize with the ventral
forebrain marker, NKX2.1. (C): A
small proportion of GFPþ cells
coexpress NKX6.1þ (arrow).
NKX6.1þ/GFP  cells are also
seen in the GLI1-infected neuro-
spheres. (D): Corinþ/GFPþ cells
can be identiﬁed within the neuro-
spheres (arrow), along with
Corin /GFPþ cells and Corinþ/
GFP  cells. (E): Cells infected
with GFP control lentivirus did not
show any GFPþ/FOXA2þ cells.
Scale bar ¼ 100 lm. Abbrevia-
tions: EF1a, Elongation Factor 1 a;
GFP, Green Fluorescent Protein;
IRES, Internal ribosome entry site.
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speciﬁes the ventral midline cells to a FP fate [14]. In this
study, we showed that human recombinant SHH treatment
of hESC during neural induction is capable of inhibiting a
dorsal neural fate and promotes expression of the basal neu-
ral tube marker, NKX6.1. However, despite having a shift
to more ventral cell types, there was no signiﬁcant increase
in FOXA2 expression, even when high concentrations of
recombinant SHH were used. One possible explanation is
that the PA6 feeder layer does not allow high levels of SHH
signaling to occur, due to other inhibiting factors. Indeed,
Fasano et al. [24] showed FP speciﬁcation by combining the
Dkk1 inhibitor together with mouse recombinant SHH, sug-
gesting that other cofactors may enhance ventralization of
the neural progenitors. Alternatively, or perhaps in addition
to, the effectiveness of SHH on promoting FP fate in neural
progenitors may be temporally dependent. In the embryo,
SHH released by the notochord induces FP development
Figure 7. GLI1-transduced neural stem cells can differentiate into neurons (stage C0) and express dopamine marker, TH. (A–N): Both
FOXA2þ/TUJ1þ cells (A–G) and FOXA2þ/THþ cells (H–N) are found in the differentiated GLI1-transduced cultures. (O): Control GFP lenti-
virus infected cultures differentiate into neurons with a subset expressing TH, however, no cells colocalized with FOXA2. (P): Bar graph showing
percentage of cells expressing both GFP and FOXA2 within the GLI1-infected cells and GFP lentiviral control cells at stage C0. There was a sig-
niﬁcant increase (p < .0067) in FOXA2 expression in GLI1-transduced cells 25.37% (63.106 SEM) FOXA2þ cells compared with GFP control
lentiviral cultures 0.08% (60.076 SEM) FOXA2þ cells. Scale bar ¼ 100 lm( A, H, O), 10 lm( B–G, I–N). Abbreviations: Ef1a, Elongation
Factor 1 a, IRES, Internal ribosome entry site; GFP, Green Fluorescent Protein; TH, tyrosine hydroxylase; TUJ1, b-III tubulin.
Denham, Thompson, Leung et al. 1813
www.StemCells.comwhich in turn establishes a SHH gradient for patterning the
basal plate of the neural tube. Thus, inducing a FP identity
requires early and high levels of SHH exposure during neu-
ral induction. Using the PA6 coculture system, expression
of neural patterning factors were detected relatively early,
at the neural induction stage (stage A), suggesting an early
onset of commitment to neuronal identity. Indeed, mouse
DA speciﬁcation has also been shown to occur early during
differentiation on PA6 cells [17]. Thus, a modiﬁed culture
system was established to remove the PA6 feeder layer and
also to allow a longer temporal window whereby hESC-
derived neural progenitors show no expression of dorsoven-
tral regional markers. Using this deﬁned culture system, we
again could not induce signiﬁcant proportions of FOXA2-
positive cells when exposed to recombinant SHH.
SHH is endogenously synthesized as a full-length precur-
sor that undergoes autoproteolytical cleavage. The ﬁnal N-ter-
minal product has a cholesterol group added to its C-terminus
and a palmitoyl group to the N-terminus. Both lipid modiﬁca-
tions affect the range and potency of SHH action, thereby
also regulating its morphogenic gradient. One of these factors
is the ability of the lipid-modiﬁed SHH to form an oligomer
[35]. The lipid-modiﬁed SHH can only be secreted via its
interaction with DISP1 [36]. Commercially available recombi-
nant SHH proteins are not lipid-modiﬁed and are therefore
less potent in their activity due to their inability to form
oligomers [35, 36]. During the review period of our study,
Fasano et al. described a more potent, modiﬁed version of
recombinant mouse SHH (C25II) which showed to induce a
FP phenotype in neural progenitors derived from hESC [24].
In vivo secretion of N-terminal SHH protein, although can
partially rescue the phenotype of SHH null mice, there is still
an observed contraction of the dorsoventral cell types found
within the neural tube [37]. This contraction is attributed to
the failure for nonlipid-modiﬁed SHH to accumulate on the
apical surface of cells and a reduction of SHH activity in its
monomeric form. These data indicates that SHH potency is
far less effective when administered exogenously, adding to
the notion that high levels of SHH are required for ventral
cell type speciﬁcation.
The insufﬁcient potency of using recombinant SHH, as
described earlier, led us to explore an alternative approach
to intrinsically specify hESC-derived neural progenitors
cells to a FP fate. SHH acts upstream of FOXA2, which
then further induces the expression of SHH, creating a posi-
tive feedback cycle. GLI1 is also a downstream target of
SHH signaling and is known to upregulate FOXA2 expres-
sion. Previous studies in mice showed that forced Gli1
expression in the dorsal neural tube results in ectopic
FoxA2 expression [15], suggesting that Gli1 may be an
appropriate candidate for inducing FP fate in neural progen-
itors. Our data show that GLI1 was capable of ventralizing
hESCs-derived early neural rosettes into FP cells as indi-
cated by the coexpression of FOXA2 and Corin. More
importantly, neurospheres derived from GLI1/GFP-trans-
duced cultures showed a signiﬁcant increase in GFP /
FOXA2þ and GFP-/NKX6.1þ cells, which were observed
to be in close proximity to the GFPþ/GLI1þ cells. This
effect may be due to localized SHH released from GLI1/
GFP-transduced cells and/or silencing of the GLI1/GFP con-
struct. The coculture experiments, using GLI1-transduced
ENVY hESCs (that constitutively expresses GFP) cocul-
tured with non-GFP HES-3, also showed localized upregu-
lated expression of FOXA2 in non-GFP expressing cells,
thereby supporting the former hypothesis. RT-PCR analyses
detected SHH transcripts in GLI1-transduced cultures, fur-
ther suggesting a paracrine effect of GLI1-expressing pro-
genitors to secrete SHH, indicative of FP action in vivo.
Furthermore, SHH produced by the GLI1-expressing cells
would presumably be secreted in the lipid-modiﬁed oligo-
meric form and thus act more potently than exogenous
administration of nonlipid-modiﬁed recombinant SHH.
Taken together, these data show that the GLI1-expressing
cells mechanistically recapitulate the neural tube FP.
The timing of GLI1 expression in neural progenitors is
also critical for inducing a FP. In the mouse, only an early
(E7.5–E8.5) transient population of Gli1-expressing cells in
the FP region of the neural tube have been shown to give
rise to mesDA neurons [7]. At later stages of development,
Gli1 is expressed in more basal regions of the neural tube
and are no longer fated to FP. These results highlight the
importance of inducing Gli1 expression in uncommitted
neural progenitors at early stages during their differentiation
to promote their speciﬁcation toward a FP lineage, which
then later may give rise to ventral neural progenitors includ-
ing mesDA neurons.
Our data showed low levels of midbrain neural patterning
markers in the differentiated GLI1-transduced cultures. This
suggests that, in addition to ventralizing factors, anterior/poste-
rior specifying factors are required to generate mesDA neural
progenitors. For example, addition of exogenous Fibroblast
Growth Factor 8 (FGF8) and Wnt1 into culture systems have
extensively been used to spatially pattern the anterior-posterior
axis of cells into a midbrain region [22, 29, 38, 39]. Wnt1 has
also been shown to directly regulate Lmx1a with an autoregula-
tory loop being formed, which then regulates Pitx3 and Nurr1
expression [39, 40]. Furthermore, the SHH/FoxA2 pathway
positively regulates Nurr1 and Ngn2 expression and inhibits
Nkx2.2 [40, 41]. The interaction of these two pathways com-
bined are critical in the efﬁcient production of mDA neurons
from hESCs and the inhibition of alternate cell fates [24]. Our
data shows GLI1 as a determinant in activating the SHH/
FOXA2 pathway by generating FP cells.
CONCLUSION
Our research demonstrated that proper ventralization of neu-
rons prior to commitment into a dorsoventral identity is essen-
tial in generating FP cells. We have shown that the differen-
tiation of induced FP cells by forced GLI1 expression can
give rise to ventral DA neurons, which is an important step in
generating a homogeneous population of mesDA neurons. In
summary, this study describes the generation of FP cells from
hESC using a single intrinsic factor, GLI1, which may serve
as a foundation for deriving various ventral neuronal popula-
tions, including mesDA for treating Parkinson’s disease.
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